Recent advances in the management of pancreatic adenocarcinoma

Karakas Y., LAÇİN Ş., YALÇIN Ş.

EXPERT REVIEW OF ANTICANCER THERAPY, cilt.18, sa.1, ss.51-62, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 18 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1080/14737140.2018.1403319
  • Dergi Adı: EXPERT REVIEW OF ANTICANCER THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.51-62
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Pancreatic cancer (PC) demonstrates very poor prognosis and its incidence continues to increase, despite developments in chemotherapy, radiotherapy, and targeted therapies. Surgical resection is currently the only curative approach for PC. The role of radiotherapy in adjuvant and locally advanced PC continues to be increasingly controversial. This review article aims to explore the current knowledge of pancreatic adenocarcinoma, focusing on diagnosis, treatment strategies, and the best supportive care.